Concepedia

CLINICAL PREDICTORS OF SUSTAINED INTRAOCULAR PRESSURE ELEVATION DUE TO INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY

Quan V. Hoang, Angela Tsuang, Rony Gelman, Luís Mendonça, Kara E. Della Torre, Jesse J. Jung, K. Bailey Freund

Retina · 2012 · 98 citations · 20 references

DOI

Abstract

A greater number of intravitreal anti-vascular endothelial growth factor injections is associated with an increased risk for sustained IOP elevation in eyes with neovascular age-related macular degeneration receiving intravitreal ranbizumab and/or bevacizumab.

References

20

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text

Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

David M. Brown, Peter K. Kaiser, Mark Michels et al. · New England Journal of Medicine · 2006 · 3.5K citations

Pegaptanib for Neovascular Age-Related Macular Degeneration

Evangelos S. Gragoudas, Anthony P. Adamis, Emmett T. Cunningham et al. · New England Journal of Medicine · 2004 · 2.3K citations · Full text

Pegaptanib Sodium for Neovascular Age-Related Macular Degeneration

Donald J. D’Amico · Ophthalmology · 2006 · 261 citations

, , +5

Short-term Intraocular Pressure Changes Immediately After Intravitreal Injections of Anti–Vascular Endothelial Growth Factor Agents

Judy E. Kim, Anand V. Mantravadi, Elizabeth Y. Hur et al. · American Journal of Ophthalmology · 2008 · 243 citations

, , +9